High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for patients with previously irradiated recurrent medulloblastoma

被引:0
|
作者
Dunkel, Ira [1 ]
Gardner, Sharon [2 ]
Garvin, James [3 ]
Goldman, Stewart [4 ]
Shi, Weiji [1 ]
Finlay, Jonathan [5 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] NYU, Med Ctr, New York, NY 10016 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY USA
[4] Childrens Mem Hosp, Chicago, IL 60614 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:480 / 480
页数:1
相关论文
共 50 条
  • [21] High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma
    Dunkel, IJ
    Finlay, JL
    JOURNAL OF NEURO-ONCOLOGY, 1996, 29 (01) : 69 - 74
  • [22] High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma
    Falzetti, Franca
    Di Ianni, Mauro
    Ballanti, Stelvio
    Iodice, Giuseppe
    Reale, Antonia
    Minelli, Olivia
    Serio, Gabriella
    Martelli, Massimo F.
    Dammacco, Franco
    Vacca, Angelo
    Ria, Roberto
    CLINICAL AND EXPERIMENTAL MEDICINE, 2012, 12 (03) : 165 - 171
  • [23] HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE AND AUTOLOGOUS STEM-CELL RESCUE IN THE TREATMENT OF NON-HODGKIN LYMPHOMA
    SIEGERT, W
    PATHOLOGIE BIOLOGIE, 1993, 41 (01): : 104 - 104
  • [24] Evaluation of the efficacy of high-dose chemotherapy (HDC) plus autologous stem cell rescue (ASCR) ± radiotherapy (RT) or standard salvage therapy in children with recurrent medulloblastoma (MBL)
    Gururangan, Sridharan
    Krauser, Jeanne
    Watral, Melody
    Driscoll, Timothy
    Larrier, Nicole
    Fuchs, Herbert
    Reardon, David
    Vredenburgh, James
    Quinn, Jennifer
    Desjardins, Annick
    Rich, Jeremy
    Friedman, Henry
    NEURO-ONCOLOGY, 2007, 9 (04) : 540 - 540
  • [25] Thiotepa-based high-dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors
    Modak, S
    Gardner, S
    Dunkel, IJ
    Balmaceda, C
    Rosenblum, MK
    Miller, DC
    Halpern, S
    Finlay, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) : 1934 - 1943
  • [26] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL RESCUE FOR RECURRENT MEDULLOBLASTOMA/CNS PNET - A SINGLE CENTER REVIEW
    Marques, J.
    Costa, I.
    Passos, J.
    Azevedo, A.
    Salgado, D.
    Teixeira, G.
    Ferreira, I.
    Guimaraes, A.
    Miranda, N.
    Abecasis, M.
    NEURO-ONCOLOGY, 2012, 14 : 91 - 91
  • [27] High-dose cyclophosphamide, carboplatin and etoposide (CCbE) with autologous stem cell rescue for breast cancer feasibility and toxicity study in 90 patients.
    Baena, JM
    Garzón, S
    Rueda, A
    Rubio, V
    Alonso, E
    Correa, MA
    Gómez, MJ
    Eddie, JP
    Contreras, JA
    Salvador, J
    León, A
    Senra, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S57 - S57
  • [28] High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors
    Antonio Pérez-Martínez
    Alvaro Lassaletta
    Marta González-Vicent
    Julián Sevilla
    Miguel Angel Díaz
    Luis Madero
    Journal of Neuro-Oncology, 2005, 71 : 33 - 38
  • [29] High-dose chemotherapy with autologous stem cell rescue for children with high risk and recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors
    Pérez-Martínez, A
    Lassaletta, A
    González-Vicent, M
    Sevilla, J
    Díaz, MA
    Madero, L
    JOURNAL OF NEURO-ONCOLOGY, 2005, 71 (01) : 33 - 38
  • [30] Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation
    Agaliotis, DP
    Ballester, OF
    Mattox, T
    Hiemenz, JW
    Fields, KK
    Zorsky, PE
    Goldstein, SC
    Perkins, JB
    Rosen, RM
    Elfenbein, GJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1997, 314 (05): : 292 - 298